Jacobs Levy Equity Management, Inc Icad Inc Transaction History

Jacobs Levy Equity Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$4.53 - $7.0 $170,844 - $263,998	-37,714 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$3.65 - $6.05 $80,497 - $133,426	-22,054 Reduced 36.9%	37,714 $195,000
Q4 2018 Feb 14, 2019	BUY	$2.54 - $4.34 $11,059 - $18,896	4,354 Added 7.86%	59,768 $221,000
Q1 2018 May 15, 2018	BUY	$2.96 - $4.0 $13,320 - $18,000	4,500 Added 8.84%	55,414 $171,000
Q4 2017 Feb 13, 2018	BUY	$3.38 - $4.74 $81 - $113	24 Added 0.05%	50,914 $175,000
Q3 2017 Nov 14, 2017	BUY	$3.3 - $4.42 $54,047 - $72,390	16,378 Added 47.46%	50,890 $225,000
Q2 2017 Nov 09, 2017	BUY	N/A	34,512	34,512 $145,000

5.48M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $73.7M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.